GlassScriptPhysician profile
Uday Hiremath
NPI 1497747216
$769.76
in general payments reported to CMS, 2019-2025
13 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.96 · 2021: $11.29 · 2022: $55.92 · 2023: $304 · 2024: $241 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $212.64 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $154.15 | 2023-2024 | Jornay Pm |
| Seqirus USA INC | $67.46 | 2024-2025 | Flucelvax |
| Astrazeneca Pharmaceuticals LP | $62.82 | 2023-2024 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $48.40 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $46.93 | 2024-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $39.61 | 2024 | Gardasil 9, Vaxelis, Gardasil |
| Cranial Technologies, INC | $39.10 | 2022-2023 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $35.31 | 2024-2025 | Zoryve |
| Collegium Pharmaceutical, INC. | $17.99 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $16.96 | 2020 | |
| Genentech USA, INC. | $14.39 | 2022 | |
| Glaxosmithkline, LLC. | $14.00 | 2023 | Bexsero, Pediarix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uday Hiremath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.